This new 262-page report from VPGMarketResearch provides a comprehensive analysis of the US drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene.
During the next five years, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
2015-2019 Future Horizons and Growth Strategies in the US Drugs of Abuse Testing Market is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; and provides test volume and sales forecasts, by market segment and individual assay.
Contains 262 pages and 12 tables
SIMILAR MARKET STUDIES
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.SummaryThis comprehensive report contains 406 pages, 38 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the German coagulation testing market during the next five years. The report explores business ...
October 2015 | $3950 | View Details >>
This new report from VPGMarketResearch provides analysis of LDH testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratories POC/Decentralized Testing - Physician Offices/Group Practices ...
October 2015 | $0 | View Details >>
Complete report $6,200. DataPack (test volumes, sales forecasts, supplier shares) $3,900. VPGMarketResearch.com's new study is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the U.K. hematology and flow cytometry markets during the next five years. The report explores business and technological trends in the U.K. ...
March 2016 | $0 | View Details >>
2014-2018 POC Lipid Testing Market: Physician Offices, Emergency Rooms, Ambulatory Care Centers. This new 340-page report from Venture Planning Group contains 36 tables, and provides a comprehensive analysis of the POC lipid testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and ...
November 2014 | $2800 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research